634. Deputy Billy Kelleher asked the Minister for Health the occasions on which a pharmaceutical company has successfully sought to increase the price charged to the HSE for a product by more than 20% in each of the years 2014 to 2017 and to date in 2018; the product involved; the reason given by the company for seeking the price increase; and the overall annual increase in the cost of the drug to the HSE resultant from such an increase in tabular form. [12677/18]

Summary

634. Deputy Billy Kelleher asked the Minister for Health the occasions on which a pharmaceutical company has successfully sought to increase the price charged to the HSE for a product by more than 20% in each of the years 2014 to 2017 and to date in 2018; the product involved; the reason given by the company for seeking the price increase; and the overall annual increase in the cost of the drug to the HSE resultant from such an increase in tabular form. [12677/18]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Prices

  xml · EN · 20 March 2018

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.